Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden

This study evaluated potential of serum tumor markers to predict the incidence and intensity of pancreatic cancer metastasis as well as patient survival. Retrospective records from 905 patients and prospective data from 142 patients were collected from two high-volume institutions. The levels of eig...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Liu, Liang, Xu, Hua-Xiang, Wang, Wen-Quan, Wu, Chun-Tao, Xiang, Jin-Feng, Liu, Chen, Long, Jiang, Xu, Jin, Fu, De-Liang, Ni, Quan-Xing, Houchen, Courtney W., Postier, Russell G., Li, Min, Yu, Xian-Jun
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868732/
https://ncbi.nlm.nih.gov/pubmed/26745601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6819
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items